To better contextualize the mechanisms associated with ferroptosis and PARP inhibitors in ovarian cancer, this section outlines the biochemical foundations of ferroptosis and its distinct features compared with classical cell death pathways. This evidence concerns the gene PARP1 and ovarian carcinoma.